Ken Johnson's Insider Trades & SAST Disclosures
Ken Johnson's most recent trade in Xeris Biopharma Holdings Inc was a trade of 25,842 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ken Johnson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 25,842 | 320,446 (1%) | 0% | 3.6 | 91,998 | Common Stock |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 15,476 | 346,288 (1%) | 0% | 3.6 | 55,095 | Common Stock |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 12,401 | 361,764 (1%) | 0% | 3.6 | 44,768 | Common Stock |
| Cable One Inc | Kenneth E. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 373.32 per share. | 03 Jan 2025 | 2,571 | 6,594 (0%) | 0% | 373.3 | 959,806 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 373.32 per share. | 03 Jan 2025 | 283 | 4,023 (0%) | 0% | 373.3 | 105,650 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 457.63 per share. | 01 Mar 2024 | 262 | 4,306 (0%) | 0% | 457.6 | 119,899 | Common Stock, par value $0.01 |
| Xeris Biopharma Holdings Inc | Johnson Ken | See Remarks | 31 Jan 2024 | 175,000 | 446,860 (1%) | 0% | 0 | Common Stock | ||
| Cable One Inc | E. Kenneth Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 1,330 | 4,044 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Cable One Inc | Kenneth E. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 541.35 per share. | 03 Jan 2024 | 190 | 2,714 (0%) | 0% | 541.4 | 102,857 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 311 | 2,904 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 31 Jan 2023 | 100,000 | 269,783 (0%) | 0% | 0 | Common Stock | ||
| Cable One Inc | Kenneth E. Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 603 | 2,593 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Cable One Inc | Kenneth E. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 696.09 per share. | 03 Jan 2023 | 135 | 1,990 (0%) | 0% | 696.1 | 93,972 | Common Stock, par value $0.01 |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 58.53 per share. | 31 Mar 2022 | 1,326 | 21,914 (0%) | 0% | 58.5 | 77,611 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 58.53 per share. | 31 Mar 2022 | 884 | 20,588 (0%) | 0% | 58.5 | 51,741 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.05 per share. | 29 Mar 2022 | 75 | 19,704 (0%) | 0% | 61.1 | 4,579 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.69 per share. | 25 Mar 2022 | 217 | 19,779 (0%) | 0% | 59.7 | 12,953 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 14 Mar 2022 | 2,900 | 19,996 (0%) | 0% | 61.5 | 178,350 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 61.28 per share. | 07 Mar 2022 | 576 | 23,070 (0%) | 0% | 61.3 | 35,297 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.28 per share. | 07 Mar 2022 | 174 | 22,896 (0%) | 0% | 61.3 | 10,663 | Common Stock, $0.01 par value per share |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 404 | 2,125 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 15,131 | 373,036 (1%) | 0% | 2.5 | 37,222 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 12,400 | 425,736 (1%) | 0% | 1.1 | 13,888 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 12,400 | 398,914 (1%) | 0% | 2.2 | 27,776 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 11,029 | 414,707 (1%) | 0% | 1.3 | 13,897 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 10,747 | 388,167 (1%) | 0% | 2.7 | 28,587 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 7,497 | 440,443 (1%) | 0% | 2.1 | 15,819 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 3,393 | 411,314 (1%) | 0% | 1.2 | 4,207 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2022 | 2,307 | 438,136 (1%) | 0% | 2.1 | 4,868 | Common Stock | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 03 Jan 2022 | 75,000 | 165,865 (0%) | 0% | 0 | Common Stock | ||
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 193 | 1,721 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1743.81 per share. | 03 Jan 2022 | 81 | 1,528 (0%) | 0% | 1743.8 | 141,249 | Common Stock, par value $0.01 |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 78,333 | 0 (0%) | 0% | - | Common Stock | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 78,333 | 89,583 (0%) | 0% | - | Common Stock | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 39,633 | 39,633 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 39,633 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 33,686 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 33,686 | 33,686 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 32,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 21,401 | 21,401 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 21,401 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 11,250 | 78,333 (0%) | 0% | - | Common Stock | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 11,250 | 11,250 (0%) | 0% | - | Common Stock | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 5,280 | 0 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 05 Oct 2021 | 5,280 | 5,280 | - | - | Stock Option (Right to Buy) | ||
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1829.29 per share. | 02 Apr 2021 | 14 | 1,609 (0%) | 0% | 1829.3 | 25,610 | Common Stock, par value $0.01 |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.59 per share. | 29 Mar 2021 | 75 | 23,868 (0%) | 0% | 54.6 | 4,094 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 55.96 per share. | 26 Mar 2021 | 1,779 | 24,071 (0%) | 0% | 56.0 | 99,553 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 55.96 per share. | 26 Mar 2021 | 1,186 | 22,292 (0%) | 0% | 56.0 | 66,369 | Common Stock, $0.01 par value per share |
| Banner Corp. | Kenneth W. Johnson | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.25 per share. | 26 Mar 2021 | 128 | 23,943 (0%) | 0% | 55.3 | 7,072 | Common Stock, $0.01 par value per share |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 392 | 1,623 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 29 Jan 2021 | 65,000 | 91,890 (0%) | 0% | 0 | Common Stock | ||
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2021 | 126 | 1,231 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2227.71 per share. | 03 Jan 2021 | 70 | 1,105 (0%) | 0% | 2227.7 | 155,940 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 719.01 per share. | 25 Nov 2020 | 1,098 | 2,273 (0%) | 0% | 719.0 | 789,473 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 1,098 | 366 | - | - | Stock Appreciation Rights | |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale or transfer of securities back to the company at price $ 1975.00 per share. | 25 Nov 2020 | 400 | 1,873 (0%) | 0% | 1975 | 790,000 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale of securities on an exchange or to another person at price $ 1960.00 per share. | 25 Nov 2020 | 377 | 1,496 (0%) | 0% | 1960 | 738,920 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale of securities on an exchange or to another person at price $ 1973.20 per share. | 25 Nov 2020 | 200 | 1,175 (0%) | 0% | 1973.2 | 394,640 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale of securities on an exchange or to another person at price $ 1971.18 per share. | 25 Nov 2020 | 110 | 1,375 (0%) | 0% | 1971.2 | 216,830 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale of securities on an exchange or to another person at price $ 1966.17 per share. | 25 Nov 2020 | 6 | 1,485 (0%) | 0% | 1966.2 | 11,797 | Common Stock, par value $0.01 |
| Cable One Inc | Kenneth E. Johnson | SVP, Technology Services | Sale of securities on an exchange or to another person at price $ 1962.20 per share. | 25 Nov 2020 | 5 | 1,491 (0%) | 0% | 1962.2 | 9,811 | Common Stock, par value $0.01 |
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 14 Aug 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Ken Johnson | See Remarks | 30 Jun 2020 | 775 | 26,890 (0%) | 0% | 2.3 | 1,752 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges